Study of Oral PG-116800 Following a Heart Attack

Completed · Phase 2 · Has a placebo group

Conditions studied: Myocardial Infarction, Heart Failure, Heart Enlargement

In brief

The main purpose of the study is to test whether a possible new drug (called PG-116800) can prevent some of the damage to heart muscle in patients who have had a heart attack. The study will also supply information regarding possible uses of this compound in cardiovascular disease.

Key facts

Study ID
NCT00067236
Run by
Procter and Gamble
People needed
253
Starts
2003-09-01
Expected to finish
2004-12-01
Last updated by the study team
2011-11-04

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.